Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech

Companies willing to invest shrewdly in the downturn will emerge from it stronger.

As the world locked down and masked up, M&A endured. Bain's third annual Global M&A Report details how companies are using mergers and acquisitions to grow.